Targeting CLDN18. 2 in cancers of the gastrointestinal tract: New drugs and new indications

J Chen, Z Xu, C Hu, S Zhang, M Zi, L Yuan… - Frontiers in …, 2023 - frontiersin.org
Cancers of the gastrointestinal (GI) tract greatly contribute to the global cancer burden and
cancer-related death. Claudin-18.2 (CLDN18. 2), a transmembrane protein, is a major …

Claudin-18.2 as a therapeutic target in cancers: cumulative findings from basic research and clinical trials

D Kyuno, A Takasawa, K Takasawa, Y Ono… - Tissue …, 2022 - Taylor & Francis
Claudins are major components of tight junctions that maintain cell polarity and intercellular
adhesion. The dynamics of claudins in cancer cells have attracted attention as a therapeutic …

Environmental and lifestyle risk factors in the carcinogenesis of gallbladder cancer

P Pérez-Moreno, I Riquelme, P García, P Brebi… - Journal of personalized …, 2022 - mdpi.com
Gallbladder cancer (GBC) is an aggressive neoplasm that in an early stage is generally
asymptomatic and, in most cases, is diagnosed in advanced stages with a very low life …

Mucin glycans: A target for cancer therapy

L Sun, Y Zhang, W Li, J Zhang, Y Zhang - Molecules, 2023 - mdpi.com
Mucin glycans are an important component of the mucus barrier and a vital defence against
physical and chemical damage as well as pathogens. There are 20 mucins in the human …

Therapeutic targets of monoclonal antibodies used in the treatment of cancer: Current and emerging

B Effer, I Perez, D Ulloa, C Mayer, F Muñoz, D Bustos… - Biomedicines, 2023 - mdpi.com
Cancer is one of the leading global causes of death and disease, and treatment options are
constantly evolving. In this sense, the use of monoclonal antibodies (mAbs) in …

[HTML][HTML] In Silico Insights Reveal Fibronectin 1 as a Theranostic Marker in Gastric Cancer

T Millapán, Á Gutiérrez, K Rosas, K Buchegger… - International Journal of …, 2024 - mdpi.com
Gastric cancer (GC) is a complex and highly variable disease, ranking among the top five
cancers diagnosed globally, and a leading cause of cancer-related deaths. Emerging from …

Construction of a Human Immune Library from Gallbladder Cancer Patients for the Single-Chain Fragment Variable (scFv) Antibody Selection against Claudin 18.2 …

B Effer, D Ulloa, C Dappolonnio, F Muñoz… - Antibodies, 2024 - mdpi.com
Gallbladder cancer (GBC) is a very aggressive malignant neoplasm of the biliary tract with a
poor prognosis. There are no specific therapies for the treatment of GBC or early diagnosis …

Membranous and nuclear staining of CLDN18 in HPV‐independent and HPV‐associated endocervical adenocarcinomas

X Du, Y Hu, X Ji, L Sui, Q Zheng, K Song, T Lv… - Cancer …, 2023 - Wiley Online Library
Objectives A classification system for endocervical adenocarcinoma (ECA) based on high‐
risk human papillomavirus (HPV) status has been established; however, the …

Understanding the clinical significance of MUC5AC in biliary tract Cancers

KK Benson, A Sheel, S Rahman, A Esnakula, A Manne - Cancers, 2023 - mdpi.com
Simple Summary Biliary tract cancers (BTC) are tumors arising from cells lining ducts in the
liver that facilitate the transport of bile into the gastrointestinal tract. They are often divided …

Subgrouping testicular germ cell tumors based on immunotherapy and chemotherapy associated lncRNAs

J Cao, Z Liu, J Yuan, Y Luo, J Wang, J Liu, H Bo, J Guo - Heliyon, 2024 - cell.com
Testicular germ cell tumors (TGCT) are the most common reproductive system malignancies
in men aged 15–44 years, accounting for 95% of all testicular tumors. Our previous studies …